These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15832257)

  • 21. Carbapenems: a potent class of antibiotics.
    Nicolau DP
    Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic resistance in children with recurrent or complicated urinary tract infection.
    Younis N; Quol K; Al-Momani T; Al-Awaisheh F; Al-Kayed D
    JNMA J Nepal Med Assoc; 2009; 48(173):14-9. PubMed ID: 19529052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro resistance of a 4-quinolone after two years of clinical use.
    Drlicek M; Grisold W; Armbruster C; Vetter N
    J Chemother; 1989 Jul; 1(4 Suppl):378-9. PubMed ID: 16312448
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antibacterial therapy of urological infections].
    Georgian Med News; 2007 Mar; (144):53-65. PubMed ID: 17473336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
    Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
    Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synthesis and antibacterial activity of 7-(3-amino-4-alkoxyimino-1 -piperidyl) -quinolones].
    Wang XY; Guo Q; Wang YC; Liu BQ; Liu ML; Sun LY; Guo HY
    Yao Xue Xue Bao; 2008 Aug; 43(8):819-27. PubMed ID: 18956774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
    Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
    Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging quinoline- and quinolone-based antibiotics in the light of epidemics.
    Kaur P; Anuradha ; Chandra A; Tanwar T; Sahu SK; Mittal A
    Chem Biol Drug Des; 2022 Dec; 100(6):765-785. PubMed ID: 35128812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between 4-quinolone antibacterials and multivalent metal ions.
    Smith JT
    J Chemother; 1989 Jul; 1(4 Suppl):134-5. PubMed ID: 16312339
    [No Abstract]   [Full Text] [Related]  

  • 31. 10 years' experience with the pneumococcal quinolone moxifloxacin.
    Burkhardt O; Welte T
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):645-68. PubMed ID: 19681692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemical structure of quinolones and their antibacterial activity. II. 4-quinolones: their occurrence in nature and biological properties].
    Milata V
    Ceska Slov Farm; 2000 Mar; 49(2):68-74. PubMed ID: 10953446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinolones and where they fit in today's environment of multidrug-resistant bugs.
    Blondeau JM; Farshad S
    Expert Rev Clin Pharmacol; 2012 Nov; 5(6):609-11. PubMed ID: 23234320
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
    Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
    Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electronic antibiotic stewardship--reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting.
    Buising KL; Thursky KA; Robertson MB; Black JF; Street AC; Richards MJ; Brown GV
    J Antimicrob Chemother; 2008 Sep; 62(3):608-16. PubMed ID: 18550680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotics for respiratory, ear and urinary tract disorders and consistency among GPs.
    Ong DS; Kuyvenhoven MM; van Dijk L; Verheij TJ
    J Antimicrob Chemother; 2008 Sep; 62(3):587-92. PubMed ID: 18544602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The quinolones: past, present, and future.
    Andriole VT
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S113-9. PubMed ID: 15942877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antibacterial activity of 7-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl) quinolones.
    Zhu B; Marinelli BA; Goldschmidt R; Foleno BD; Hilliard JJ; Bush K; Macielag MJ
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4933-6. PubMed ID: 19646867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.